Gelonghui, April 26, 丨 Zaiding Pharmaceutical (09688.HK) announced that the Board Review Committee will review and approve (including) the unaudited quarterly results (“First Quarter Results”) of the Company and its subsidiaries for the 3 months ended March 31, 2024, prepared in accordance with US GAAP and applicable rules of the US Securities and Exchange Commission (“First Quarter Results”).
If the first quarter results are approved by the Audit Committee, the company will publish the first quarter results announcement on the Hong Kong Stock Exchange Limited website on May 8, 2024 (Wednesday, US Eastern Time) /May 9, 2024 (Thursday, Hong Kong time).